2009 International Marketing Partner | Speaking FacultyWho is Speaking at Partnerships in Clinical Trials Asia Pacific? | Jennifer Driscoll, Safety Area Manager Asia Pacific, Global Drug Safety Interface Management Group, MERCK SERONO, Singapore |  | Simon Britton, Vice President, Clinical Development, Asia Pacific, PPD, USA |  | Joye Emmens, Director, Global Strategic Sourcing, AMGEN, USA
|  | Joan Shen, MD, PhD, Director, CNS, Clinical Research and Development, WYETH RESEARCH, USA |  | James Cai, Senior Vice President of Clinical Development, ATYR PHARMA & President, PANGU BIOPHARMA, China |  | Dr. Narendra Maharaj, General Manager, Global Clinical Operations, Glenmark Research Centre, GLENMARK PHARMACEUTICALS, India |  | Sue Dubman, Senior Director, Chief Data Officer, GENZYME, USA
|  | Deven Parmar, MD, Vice President - Clinical Research, WOCKHART, India |  | Frank F. Fan, Medical Director, WYETH, Hong Kong |  | Larry Fiori, Associate Director, Clinical Trial Outsourcing & Compliance, Compliance & Quality Management, BOEHRINGER INGELHEIM PHARMACEUTICALS, USA |  | Du Wen-Ming, Executive Director, Shanghai Center for Adverse Drug Reaction Monitoring, SFDA, China |  | Emilio Ledesma, Vice President, Clinical R&D and Medical Affairs, GSK BIOLOGICALS, Singapore |  | Fidela Ll. Moreno, MD, Vice President, Global Development Operations, Clinical Site Management and Monitoring, ALLERGAN, USA |  | Teoh Yee Leong, Director, Clinical R&D and Medical Affairs, GSK BIOLOGICALS, Singapore |  | Y.K. Gupta, Head, Dept. of Pharmacology, All India Institute of Medical Sciences; & Coordinator, ZONAL PHARMACOVIGILANCE CENTRE, India |  | Mark Engel, President and CEO, EXCEL PHARMASTUDIES, China |  | Sven Ohlman, Regional Director Clinical Study Operations Asia, ASTRAZENECA, Singapore |  | James Kirwin, Associate Vice President, Global Clinical Operations, WYETH PHARMACEUTICALS, USA |  | Ruiping Dong, MD, PhD, Vice President, Global Development & Medical Affairs, Asia-Pacifi c & Emerging Markets, BRISTOLMYERS SQUIBB, Japan |  | Yan Wu, MD, Medical & Clinical Development Director, BIOGEN IDEC, China |  | Albert G.S. Liou, Corporate Vice President and General Manager, Asia-Pacific Region, PAREXEL INTERNATIONAL, Taiwan |  | Yanhua Gong, Secretary General, CONTRACT RESEARCH ORGANIZATION UNION, China |  | Melvin Toh, Vice President, Pharmaceutical Development, CK LIFE SCIENCES, Hong Kong |  | Andrew Chong, Regional Head AsiaPac Offi ce of International Development, GENENTECH, Singapore | | | |  | Nguyen Ngo Quang, Expert of the Science and Training Department, Secretary of ERB, MINISTRY OF HEALTH, Vietnam |
| |